01:20 PM EDT, 09/23/2025 (MT Newswires) -- Profound Medical ( PROF ) said Tuesday that Texas Prostate and Dallas Medical Center launched the Medicare-covered Tulsa program in the US to expand access to incision-free prostate treatment.

The program will offer the Tulsa procedure for prostate cancer and benign prostatic hyperplasia patients in Dallas Medical Center's MRI suite, the company said.

Profound said the initiative provides a model for other Medicare-accepting hospitals and private practices to broaden access to the treatment.

Shares were up 12% in recent trading.

Price: 4.82, Change: +0.52, Percent Change: +11.98